Malignant bone tumors - Revision history

Rossdonaldson1: Redirected page to Bone tumors and their mimics

2019-12-11T04:52:22Z

Redirected page to Bone tumors and their mimics

← Older revision		Revision as of 04:52, 11 December 2019
Line 1:		Line 1:
	~~==Differential Diagnosis<ref>Niederhuber, John E., et al. “Sarcomas.” Abeloff's Clinical Oncology E-Book. Elsevier Health Sciences, 2019, pp. 1604 – 1654.e8.</ref>==~~		#Redirect[[Bone tumors and their mimics]]
	*[[Multiple myeloma]]
	*[[Osteosarcoma]]
	*[[Chondrosarcoma]]
	*[[~~Ewing sarcoma]]~~
	~~{\| {{table}}~~
	~~\| align="center" style="background:#f0f0f0;"\|'''Name'''~~
	~~\| align="center" style="background:#f0f0f0;"\|'''Presentation'''~~
	~~\| align="center" style="background:#f0f0f0;"\|'''Radiograph Findings'''~~
	~~\| align="center" style="background:#f0f0f0;"\|'''Clinical Importance'''~~
	\|-
	~~\| Adamantinoma\|\|~~Bone ~~pain over anterior tibia in adolescent or young adult\|\|Soap bubble osteolytic appearance on plain radiograph\|\|Metastasis to lungs; may need amputation~~
	\|-
	\| Chordoma\|\|Constant pain if in sacrum; neurological deficits if at base of skull, most commonly in cranial nerves to the eye \|\|Plain radiograph will show a destructive bone lesion often with an associated soft tissue mass\|\|Slow growing but locally aggressive; metastasis is uncommon, local recurrence is much more likely
	\|-
	~~\| Fibrosarcoma~~ and ~~Undifferentiated pleomorphic sarcoma\|\|Similar to osteosarcoma except malignant fibroblasts but less common\|\|Most common in distal femur and proximal tibia\|\|Similar outcome to osteosarcoma~~
	\|-
	~~\| Primary bone lymphoma\|\|Adult > 40 years of age with bone pain or pathologic fracture\|\|Bone destruction; soft tissue mass\|\|5 year survival is greater than 50% with radiation and chemotherapy~~
	\|}

	~~==See Also==~~
	*[[Benign bone tumors]]

	~~==References==~~
	~~<references/>~~

Mtjordan91 at 23:22, 21 November 2019

2019-11-21T23:22:28Z

← Older revision		Revision as of 23:22, 21 November 2019
Line 18:		Line 18:
	\| Primary bone lymphoma\|\|Adult > 40 years of age with bone pain or pathologic fracture\|\|Bone destruction; soft tissue mass\|\|5 year survival is greater than 50% with radiation and chemotherapy		\| Primary bone lymphoma\|\|Adult > 40 years of age with bone pain or pathologic fracture\|\|Bone destruction; soft tissue mass\|\|5 year survival is greater than 50% with radiation and chemotherapy
	\|}		\|}

			==See Also==
			*[[Benign bone tumors]]

	==References==		==References==
	<references/>		<references/>

Mtjordan91: /* Differential DiagnosisNiederhuber, John E., et al. “Sarcomas.” Abeloff's Clinical Oncology E-Book. Elsevier Health Sciences, 2019, pp. 1604 – 1654.e8. */

2019-11-21T23:10:50Z

Differential DiagnosisNiederhuber, John E., et al. “Sarcomas.” Abeloff's Clinical Oncology E-Book. Elsevier Health Sciences, 2019, pp. 1604 – 1654.e8.

← Older revision		Revision as of 23:10, 21 November 2019
Line 3:		Line 3:
	*[[Osteosarcoma]]		*[[Osteosarcoma]]
	*[[Chondrosarcoma]]		*[[Chondrosarcoma]]
	*[[Ewing ~~Sarcoma~~]]		*[[Ewing sarcoma]]
	{\| {{table}}		{\| {{table}}
	\| align="center" style="background:#f0f0f0;"\|'''Name'''		\| align="center" style="background:#f0f0f0;"\|'''Name'''

Mtjordan91: /* Disposition */

2019-11-21T23:09:37Z

Disposition

← Older revision		Revision as of 23:09, 21 November 2019
Line 18:		Line 18:
	\| Primary bone lymphoma\|\|Adult > 40 years of age with bone pain or pathologic fracture\|\|Bone destruction; soft tissue mass\|\|5 year survival is greater than 50% with radiation and chemotherapy		\| Primary bone lymphoma\|\|Adult > 40 years of age with bone pain or pathologic fracture\|\|Bone destruction; soft tissue mass\|\|5 year survival is greater than 50% with radiation and chemotherapy
	\|}		\|}

	~~==Disposition==~~

	==References==		==References==
	<references/>		<references/>

Mtjordan91: /* Management */

2019-11-21T23:09:26Z

Management

← Older revision		Revision as of 23:09, 21 November 2019
Line 18:		Line 18:
	\| Primary bone lymphoma\|\|Adult > 40 years of age with bone pain or pathologic fracture\|\|Bone destruction; soft tissue mass\|\|5 year survival is greater than 50% with radiation and chemotherapy		\| Primary bone lymphoma\|\|Adult > 40 years of age with bone pain or pathologic fracture\|\|Bone destruction; soft tissue mass\|\|5 year survival is greater than 50% with radiation and chemotherapy
	\|}		\|}

	~~==Management==~~


	==Disposition==		==Disposition==

Mtjordan91: /* Evaluation */

2019-11-21T23:09:10Z

Evaluation

← Older revision		Revision as of 23:09, 21 November 2019
Line 18:		Line 18:
	\| Primary bone lymphoma\|\|Adult > 40 years of age with bone pain or pathologic fracture\|\|Bone destruction; soft tissue mass\|\|5 year survival is greater than 50% with radiation and chemotherapy		\| Primary bone lymphoma\|\|Adult > 40 years of age with bone pain or pathologic fracture\|\|Bone destruction; soft tissue mass\|\|5 year survival is greater than 50% with radiation and chemotherapy
	\|}		\|}

	~~==Evaluation==~~


	==Management==		==Management==

Mtjordan91: /* Clinical Features */

2019-11-21T23:08:50Z

Clinical Features

← Older revision		Revision as of 23:08, 21 November 2019
Line 1:		Line 1:
	~~==Clinical Features==~~


	==Differential Diagnosis<ref>Niederhuber, John E., et al. “Sarcomas.” Abeloff's Clinical Oncology E-Book. Elsevier Health Sciences, 2019, pp. 1604 – 1654.e8.</ref>==		==Differential Diagnosis<ref>Niederhuber, John E., et al. “Sarcomas.” Abeloff's Clinical Oncology E-Book. Elsevier Health Sciences, 2019, pp. 1604 – 1654.e8.</ref>==
	*[[Multiple myeloma]]		*[[Multiple myeloma]]

Mtjordan91: /* Background */

2019-11-21T23:08:34Z

Background

← Older revision		Revision as of 23:08, 21 November 2019
Line 1:		Line 1:
	~~==Background==~~


	==Clinical Features==		==Clinical Features==

Mtjordan91: /* Differential DiagnosisNiederhuber, John E., et al. “Sarcomas.” Abeloff's Clinical Oncology E-Book. Elsevier Health Sciences, 2019, pp. 1604 – 1654.e8. */

2019-11-21T23:08:07Z

Differential DiagnosisNiederhuber, John E., et al. “Sarcomas.” Abeloff's Clinical Oncology E-Book. Elsevier Health Sciences, 2019, pp. 1604 – 1654.e8.

← Older revision		Revision as of 23:08, 21 November 2019
Line 16:		Line 16:
	\| align="center" style="background:#f0f0f0;"\|'''Clinical Importance'''		\| align="center" style="background:#f0f0f0;"\|'''Clinical Importance'''
	\|-		\|-
	\| Adamantinoma\|\|Bone pain over anterior tibia in adolescent or young adult\|\|Soap ~~Bubble~~ osteolytic appearance on plain radiograph\|\|Metastasis to lungs; may need amputation		\| Adamantinoma\|\|Bone pain over anterior tibia in adolescent or young adult\|\|Soap bubble osteolytic appearance on plain radiograph\|\|Metastasis to lungs; may need amputation
	\|-		\|-
	\| Chordoma\|\|Constant pain if in sacrum; neurological deficits if at base of skull, most commonly in cranial nerves to the eye \|\|Plain radiograph will show a destructive bone lesion often with an associated soft tissue mass\|\|Slow growing but locally aggressive; metastasis is uncommon, local recurrence is much more likely		\| Chordoma\|\|Constant pain if in sacrum; neurological deficits if at base of skull, most commonly in cranial nerves to the eye \|\|Plain radiograph will show a destructive bone lesion often with an associated soft tissue mass\|\|Slow growing but locally aggressive; metastasis is uncommon, local recurrence is much more likely

Mtjordan91: /* Differential DiagnosisNiederhuber, John E., et al. “Sarcomas.” Abeloff's Clinical Oncology E-Book. Elsevier Health Sciences, 2019, pp. 1604 – 1654.e8. */

2019-11-21T23:07:02Z

Differential DiagnosisNiederhuber, John E., et al. “Sarcomas.” Abeloff's Clinical Oncology E-Book. Elsevier Health Sciences, 2019, pp. 1604 – 1654.e8.

← Older revision		Revision as of 23:07, 21 November 2019
Line 16:		Line 16:
	\| align="center" style="background:#f0f0f0;"\|'''Clinical Importance'''		\| align="center" style="background:#f0f0f0;"\|'''Clinical Importance'''
	\|-		\|-
	\| Adamantinoma\|\|Bone pain over anterior tibia in adolescent or young adult\|\|Soap Bubble osteolytic appearance on plain radiograph\|\|"Metastasis to lungs		\| Adamantinoma\|\|Bone pain over anterior tibia in adolescent or young adult\|\|Soap Bubble osteolytic appearance on plain radiograph\|\|Metastasis to lungs; may need amputation
	\|-		\|-
	~~\| May need amputation"~~		\| Chordoma\|\|Constant pain if in sacrum; neurological deficits if at base of skull, most commonly in cranial nerves to the eye \|\|Plain radiograph will show a destructive bone lesion often with an associated soft tissue mass\|\|Slow growing but locally aggressive; metastasis is uncommon, local recurrence is much more likely
	\|-
	\| Chordoma\|\|"Constant pain if in sacrum
	\|-
	~~\| Neurological~~ deficits if at base of skull, most commonly in cranial nerves to the eye "\|\|Plain radiograph will show a destructive bone lesion often with an associated soft tissue mass\|\|"Slow growing but locally aggressive
	\|-
	~~\| Metastasis~~ is uncommon, local recurrence is much more likely"
	\|-		\|-
	\| Fibrosarcoma and Undifferentiated pleomorphic sarcoma\|\|Similar to osteosarcoma except malignant fibroblasts but less common\|\|Most common in distal femur and proximal tibia\|\|Similar outcome to osteosarcoma		\| Fibrosarcoma and Undifferentiated pleomorphic sarcoma\|\|Similar to osteosarcoma except malignant fibroblasts but less common\|\|Most common in distal femur and proximal tibia\|\|Similar outcome to osteosarcoma
	\|-		\|-
	\| Primary bone lymphoma\|\|Adult > 40 years of age with bone pain or pathologic fracture\|\|"Bone destruction		\| Primary bone lymphoma\|\|Adult > 40 years of age with bone pain or pathologic fracture\|\|Bone destruction; soft tissue mass\|\|5 year survival is greater than 50% with radiation and chemotherapy
	\|-
	~~\| Soft~~ tissue mass"\|\|5 year survival is greater than 50% with radiation and chemotherapy
	\|}		\|}